MTX vs CBT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 30, 2026

MTX

52.5
AI Score
VS
MTX Wins

CBT

51.9
AI Score

Investment Advisor Scores

MTX

53score
Recommendation
BUY

CBT

52score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric MTX CBT Winner
Forward P/E 8.9686 9.9404 MTX
PEG Ratio 2.2199 1.0017 CBT
Revenue Growth 3.7% 6.4% CBT
Earnings Growth -28.8% -93.7% MTX
Tradestie Score 52.5/100 51.9/100 MTX
Profit Margin -3.1% 5.2% CBT
Beta 1.00 1.00 Tie
AI Recommendation BUY STRONG BUY CBT

Relative Price Performance (Last 90 Days)

MTX 1M: -3.4% · 3M: -15.3% CBT 1M: -4.2% · 3M: -16.2%

Current Technical Phase

MTX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.6%), weak momentum, RSI 42

RSI (14): 42.0 · Price: $61.64

CBT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.7%), weak momentum, RSI 43

RSI (14): 42.8 · Price: $72.29

Fundamentals Snapshot

Metric MTX CBT
Market Cap — —
Forward P/E 9.4 9.4
Trailing P/E — 17.9
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS -2.23 4.02
Dividend Yield 0.01% 0.00%

Frequently Asked Questions

Based on our detailed analysis, MTX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.